News

Regular use of aspirin or ibuprofen could lower the risk of Parkinson’s disease associated with mutations in the LRRK2 gene, a new study suggests. The study, “Nonsteroidal Anti‐Inflammatory Use and LRRK2 Parkinson’s Disease Penetrance,” was published in Movement Disorders. Mutations in LRRK2 are one…

The U.S. Food and Drug Administration (FDA) has approved a new app developed by Abbott, called the Patient Controller app, which will allow patients with chronic neurological conditions to manage personalized therapy regimens using compatible smartphones. The Patient Controller app, which is compatible with Apple’s operating system iOS, synchronizes…

Loss of the sense of smell is associated with longer disease duration in Parkinson’s, suggesting this sense increasingly fails as the disease progresses. Its decline may be a clinically useful biomarker of Parkinson’s progression and severity, the study’s researchers said. These findings were in “Association between olfactory…

Weight gain after stopping to smoke tobacco does not significantly minimize for men the protection that smoking is thought to bring against a likelihood developing Parkinson’s disease, according to a Korean nationwide study. “These findings indicate that smoking may be a much more powerful factor than weight gain” in terms of…

The Michael J. Fox Foundation has awarded a $750,000 grant to University of California, Los Angeles (UCLA) scientists working to make that state’s Parkinson’s disease registry more efficient and of greater value to doctors, researchers and patients alike. Specifically, the 18-month grant will be used to redesign the…